Horizon Technology Finance Announces Third Quarter 2023 Financial Results
- Net investment income per share was $0.53, representing an increase compared to the prior-year period.
- The debt portfolio yield was 17.1%, indicating a strong return on investments.
- The portfolio grew by 15% YoY to $729 million, demonstrating healthy growth.
- The Horizon Platform ended the quarter with a committed backlog of $222 million, highlighting a strong pipeline of future investments.
- Regular monthly distributions totaling $0.33 per share through March 2024 and a $0.05 special distribution payable in December 2023 were declared, providing consistent returns to shareholders.
- The NAV per share was impacted by stressed investments, indicating potential risks in the portfolio.
- The net realized loss on investments for the quarter was $11.8 million, reflecting negative performance in certain investments.
- The net unrealized depreciation on investments was $17.5 million, indicating a decline in the value of certain assets.
- The decrease in performance-based incentive fees contributed to a decrease in total expenses for the quarter.
- Third Quarter 2023 Net Investment Income per Share of
- Debt Portfolio Yield of
- Grew Portfolio Year over Year by
- Horizon Platform Ends Quarter with Committed Backlog of
Including
- Declares Regular Monthly Distributions Totaling
Third Quarter 2023 Highlights
- Net investment income ("NII") of
, or$17.4 million per share, compared to$0.53 , or$11.1 million per share for the prior-year period$0.43 - Total investment portfolio of
as of September 30, 2023$729.1 million - Net asset value of
, or$346.6 million per share, as of September 30, 2023$10.41 - Annualized portfolio yield on debt investments of
17.1% for the quarter - HRZN funded eight loans totaling
$88.4 million - HRZN's investment adviser, Horizon Technology Finance Management LLC ("HTFM"), originated
through its lending platform ("Horizon Platform"), inclusive of the loans funded by Horizon$88.9 million - Raised total net proceeds of approximately
with "at-the-market" ("ATM") offering program$13.9 million - Experienced liquidity events from five portfolio companies
- Cash of
and credit facility capacity of$47.3 million as of September 30, 2023$194.0 million - Held portfolio of warrant and equity positions in 99 companies as of September 30, 2023
- Undistributed spillover income of
per share as of September 30, 2023$1.23 - Subsequent to quarter end, declared distributions of
per share payable in January, February and March 2024 and a special distribution of$0.11 per share payable in December 2023$0.05
"In the third quarter, our debt portfolio yield of over
"In terms of credit, our NAV per share was impacted in the quarter by stressed investments. We continue to work diligently to ensure optimal outcomes for all of our investments," continued Mr. Pomeroy. "As we close out the year, in light of the current macro environment, persistent inflation and reduced venture investing, we will remain cautious with respect to growing HRZN's portfolio of debt investments, but believe that there remain select excellent investment opportunities."
Third Quarter 2023 Operating Results
Total investment income for the quarter ended September 30, 2023 grew
The Company's dollar-weighted annualized yield on average debt investments for the quarter ended September 30, 2023 and 2022 was
Total expenses for the quarter ended September 30, 2023 were
Net investment income for the quarter ended September 30, 2023 was
For the quarter ended September 30, 2023, net realized loss on investments was
For the quarter ended September 30, 2023, net unrealized depreciation on investments was
Portfolio Summary and Investment Activity
As of September 30, 2023, the Company's debt portfolio consisted of 56 secured loans with an aggregate fair value of
($ in thousands) | For the Three Months Ended September 30, | For the Nine Months Ended | ||
2023 | 2022 | 2023 | 2022 | |
Beginning portfolio | $ 715,391 | $ 577,492 | $ 720,026 | $ 458,075 |
New debt and equity investments | 89,435 | 94,627 | 186,988 | 348,347 |
Less refinanced debt balances | (22,500) | — | (32,500) | (25,000) |
Net new debt and equity investments | 66,935 | 94,627 | 154,488 | 323,347 |
Principal payments received on investments | (9,121) | (4,960) | (22,011) | (11,916) |
Payment-in-kind interest on investments | 3,934 | — | 6,088 | — |
Early pay-offs and principal paydowns | (16,605) | (22,000) | (68,211) | (77,517) |
Accretion of debt investment fees | 1,925 | 1,980 | 5,018 | 4,533 |
New debt investment fees | (1,595) | (1,474) | (2,397) | (4,259) |
Warrants and equity received in settlement of fee income | 80 | — | 169 | — |
Proceeds from sale of investments | (2,557) | (6,255) | (11,063) | (49,681) |
Net loss on investments | (11,816) | (8,228) | (28,513) | (9,127) |
Net unrealized (depreciation) appreciation on investments | (17,518) | 3,442 | (24,448) | 1,169 |
Other | — | — | (93) | — |
Ending portfolio | $ 729,053 | $ 634,624 | $ 729,053 | $ 634,624 |
Portfolio Asset Quality
The following table shows the classification of Horizon's loan portfolio at fair value by internal credit rating as of September 30, 2023, June 30, 2023 and December 31, 2022:
($ in thousands) | September 30, 2023 | June 30, 2023 | December 31, 2022 | ||||||||
Number of | Debt Investments | Percentage | Number of | Debt Investments | Percentage | Number of | Debt Investments | Percentage | |||
Credit Rating | |||||||||||
4 | 12 | $ 150,882 | 22.2 % | 11 | $ 151,399 | 22.2 % | 8 | $ 93,832 | 13.7 % | ||
3 | 37 | 437,158 | 64.3 % | 38 | 460,125 | 67.3 % | 47 | 557,554 | 81.2 % | ||
2 | 5 | 76,298 | 11.2 % | 4 | 61,985 | 9.1 % | 2 | 26,822 | 3.9 % | ||
1 | 2 | 15,500 | 2.3 % | 1 | 9,800 | 1.4 % | 3 | 8,250 | 1.2 % | ||
Total | 56 | $ 679,838 | 100.0 % | 54 | $ 683,309 | 100.0 % | 60 | $ 686,458 | 100.0 % |
As of September 30, 2023, June 30, 2023 and December 31, 2022, Horizon's loan portfolio had a weighted average credit rating of 3.1, with 4 being the highest credit quality rating and 3 being the rating for a standard level of risk. A rating of 2 represents an increased level of risk and, while no loss is currently anticipated for a 2-rated loan, there is potential for future loss of principal. A rating of 1 represents deteriorating credit quality and high degree of risk of loss of principal.
As of September 30, 2023, there were two debt investments with an internal credit rating of 1, with an aggregate cost of
Liquidity and Capital Resources
As of September 30, 2023, the Company had
As of September 30, 2023, there was
Additionally, as of September 30, 2023, there was
Horizon Funding Trust 2019-1, a wholly-owned subsidiary of HRZN, previously issued
Horizon Funding Trust 2022-1, a wholly-owned subsidiary of Horizon, previously issued
During the three months ended September 30, 2023, the Company sold 1,186,303 shares of common stock under its ATM offering program with Goldman Sachs & Co. LLC and B. Riley FBR, Inc. For the same period, the Company received total accumulated net proceeds of approximately
As of September 30, 2023, the Company's net debt to equity leverage ratio was
Liquidity Events
During the quarter ended September 30, 2023, Horizon experienced liquidity events from five portfolio companies. Liquidity events for Horizon may consist of the sale of warrants or equity in portfolio companies, loan prepayments, sale of owned assets or receipt of success fees.
In July, HRZN received a partial paydown of
In July, HRZN received
In August, with the proceeds of a new loan from the Horizon Platform, Sonex Health, Inc. ("Sonex") prepaid its previously outstanding principal balance of
In September, Avalo Therapeutics, Inc. ("Avalo") paid its outstanding principal balance of
In September, with the proceeds of a new loan from HRZN, BriteCore Holdings, Inc. ("BriteCore") prepaid its previously outstanding principal balance of
In addition, in July, HRZN converted
Net Asset Value
At September 30, 2023, the Company's net assets were
For the quarter ended September 30, 2023, net decrease in net assets resulting from operations was
Stock Repurchase Program
On April 28, 2023, the Company's board of directors extended the Company's previously authorized stock repurchase program until the earlier of June 30, 2024 or the repurchase of
Recent Developments
On October 27, 2023, Evelo Biosciences, Inc. ("Evelo") paid down
As of October 30, 2023, the fair value of the Company's equity investment in Evelo is
Monthly and Special Distributions Declared in Fourth Quarter 2023
On October 27, 2023, the Company's board of directors declared monthly distributions of
Monthly Distributions | |||
Ex-Dividend Date | Record Date | Payment Date | Amount per Share |
December 18, 2023 | December 19, 2023 | January 16, 2024 | |
January 17, 2024 | January 18, 2024 | February 14, 2024 | |
February 15, 2024 | February 16, 2024 | March 15, 2024 | |
Total: | |||
Special Distribution | |||
Ex-Dividend Date | Record Date | Payment Date | Amount per Share |
November 16, 2023 | November 17, 2023 | December 15, 2023 |
After paying distributions of
When declaring distributions, the Horizon board of directors reviews estimates of taxable income available for distribution, which may differ from consolidated net income under generally accepted accounting principles due to (i) changes in unrealized appreciation and depreciation, (ii) temporary and permanent differences in income and expense recognition, and (iii) the amount of spillover income carried over from a given year for distribution in the following year. The final determination of taxable income for each tax year, as well as the tax attributes for distributions in such tax year, will be made after the close of the tax year.
Conference Call
The Company will host a conference call on Wednesday, November 1, 2023, at 9:00 a.m. ET to discuss its latest corporate developments and financial results. To participate in the call, please dial (877) 407-9716 (domestic) or (201) 493-6779 (international). The access code for all callers is 13740672. The Company recommends joining the call at least 5 minutes in advance. In addition, a live webcast will be available on the Company's website at www.horizontechfinance.com.
A webcast replay will be available on the Company's website for 30 days following the call.
About Horizon Technology Finance
Horizon Technology Finance Corporation (NASDAQ: HRZN), externally managed by Horizon Technology Finance Management LLC, an affiliate of Monroe Capital, is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of Horizon is to maximize its investment portfolio's return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon is headquartered in
Forward-Looking Statements
Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Horizon's filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Contacts:
Investor Relations:
ICR
Garrett Edson
ir@horizontechfinance.com
(860) 284-6450
Media Relations:
ICR
Chris Gillick
HorizonPR@icrinc.com
(646) 677-1819
Horizon Technology Finance Corporation and Subsidiaries Consolidated Statements of Assets and Liabilities | |||||
September 30, | December 31, | ||||
2023 | 2022 | ||||
(unaudited) | |||||
Assets | |||||
Non-affiliate investments at fair value (cost of | $ 695,423 | $ 720,026 | |||
Non-controlled affiliate investments at fair value (cost of | 20,485 | — | |||
Controlled affiliate investments at fair value (cost of | 13,145 | — | |||
Total investments at fair value (cost of | 729,053 | 720,026 | |||
Cash | 34,816 | 20,612 | |||
Investments in money market funds | 12,457 | 7,066 | |||
Restricted investments in money market funds | 2,838 | 2,788 | |||
Interest receivable | 14,135 | 13,573 | |||
Other assets | 3,945 | 2,761 | |||
Total assets | $ 797,244 | $ 766,826 | |||
Liabilities | |||||
Borrowings | $ 435,500 | $ 434,078 | |||
Distributions payable | 10,991 | 9,159 | |||
Base management fee payable | 1,080 | 1,065 | |||
Incentive fee payable | — | 1,392 | |||
Other accrued expenses | 3,098 | 2,684 | |||
Total liabilities | 450,669 | 448,378 | |||
Commitments and contingencies | |||||
Net assets | |||||
Preferred stock, par value shares issued and outstanding as of September 30, 2023 and December 31, 2022 | — | — | |||
Common stock, par value 33,474,423 and 27,920,838 shares issued and 33,306,958 and 27,753,373 shares | 35 | 29 | |||
Paid-in capital in excess of par | 451,722 | 385,921 | |||
Distributable earnings | (105,182) | (67,502) | |||
Total net assets | 346,575 | 318,448 | |||
Total liabilities and net assets | $ 797,244 | $ 766,826 | |||
Net asset value per common share | $ 10.41 | $ 11.47 | |||
Horizon Technology Finance Corporation and Subsidiaries Consolidated Statements of Operations (Unaudited) | ||||||||
For the Three Months Ended | For the Nine Months Ended | |||||||
September 30, | September 30, | |||||||
2023 | 2022 | 2023 | 2022 | |||||
Investment income | ||||||||
From non-affiliate investments: | ||||||||
Interest income | $ 23,825 | $ 22,745 | $ 75,695 | $ 54,317 | ||||
Fee income | 124 | 509 | 2,255 | 1,729 | ||||
Payment-in-kind interest income | 3,777 | — | 5,930 | — | ||||
From controlled affiliate investments: | ||||||||
Interest income | 8 | — | 8 | — | ||||
Payment-in-kind interest income | 158 | — | 158 | — | ||||
From non-controlled affiliate investments: | ||||||||
Interest income | 1,246 | — | 1,246 | — | ||||
Total investment income | 29,138 | 23,254 | 85,292 | 56,046 | ||||
Expenses | ||||||||
Interest expense | 7,107 | 5,339 | 21,407 | 12,987 | ||||
Base management fee | 3,213 | 2,788 | 9,621 | 7,555 | ||||
Performance based incentive fee | — | 2,784 | 3,094 | 6,353 | ||||
Administrative fee | 441 | 412 | 1,249 | 1,147 | ||||
Professional fees | 452 | 314 | 1,558 | 1,163 | ||||
General and administrative | 392 | 381 | 1,384 | 1,088 | ||||
Total expenses | 11,605 | 12,018 | 38,313 | 30,293 | ||||
Net investment income before excise tax | 17,533 | 11,236 | 46,979 | 25,753 | ||||
Provision for excise tax | 179 | 100 | 542 | 306 | ||||
Net investment income | 17,354 | 11,136 | 46,437 | 25,447 | ||||
Net realized and unrealized loss | ||||||||
Net realized loss on non-affiliate investments | (11,816) | (8,665) | (28,513) | (8,364) | ||||
Net realized gain on non-controlled affiliate investments | — | 30 | — | 30 | ||||
Net realized gain (loss) on controlled affiliate investments | — | 50 | — | (1,150) | ||||
Net realized loss on investments | (11,816) | (8,585) | (28,513) | (9,484) | ||||
Net unrealized appreciation (depreciation) on non-affiliate investments | 180 | 3,442 | (7,656) | (281) | ||||
Net unrealized depreciation on non-controlled affiliate investments | (19,055) | — | (18,149) | — | ||||
Net unrealized appreciation on controlled affiliate investments | 1,357 | — | 1,357 | 1,450 | ||||
Net unrealized (depreciation) appreciation on investments | (17,518) | 3,442 | (24,448) | 1,169 | ||||
Net realized and unrealized loss | (29,334) | (5,143) | (52,961) | (8,315) | ||||
Net (decrease) increase in net assets resulting from operations | $ (11,980) | $ 5,993 | $ (6,524) | $ 17,132 | ||||
Net investment income per common share | $ 0.53 | $ 0.43 | $ 1.54 | $ 1.06 | ||||
Net (decrease) increase in net assets resulting from operations per common share | $ (0.37) | $ 0.23 | $ (0.22) | $ 0.71 | ||||
Distributions declared per share | $ 0.33 | $ 0.30 | $ 0.99 | $ 0.90 | ||||
Weighted average shares outstanding | 32,451,900 | 25,738,054 | 30,155,287 | 23,995,369 |
View original content:https://www.prnewswire.com/news-releases/horizon-technology-finance-announces-third-quarter-2023-financial-results-301973194.html
SOURCE Horizon Technology Finance Corporation
FAQ
What is the net investment income per share for Q3 2023?
What was the debt portfolio yield for the quarter?
What was the growth rate of the portfolio compared to the previous year?
What is the committed backlog of the Horizon Platform at the end of the quarter?